Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053849 | SCV001218131 | uncertain significance | Candidiasis, familial, 9 | 2023-05-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 849815). This variant has not been reported in the literature in individuals affected with IL17RC-related conditions. This variant is present in population databases (rs200405939, gnomAD 0.02%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 346 of the IL17RC protein (p.Val346Met). |
Ambry Genetics | RCV004031693 | SCV003939420 | uncertain significance | not specified | 2023-06-02 | criteria provided, single submitter | clinical testing | The c.1036G>A (p.V346M) alteration is located in exon 10 (coding exon 10) of the IL17RC gene. This alteration results from a G to A substitution at nucleotide position 1036, causing the valine (V) at amino acid position 346 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004693526 | SCV005187504 | uncertain significance | not provided | criteria provided, single submitter | not provided |